Skip to content
2000
Volume 7, Issue 2
  • ISSN: 2666-7967
  • E-ISSN: 2666-7975

Abstract

Introduction

COVID-19 is a deadly virus, but there is still no appropriate cure for it. Hence, the target of this study was to estimate the clinical value of thrombocytopenia and other blood parameters in COVID-19 patients referred to Ilam Shahid Mostafa Khomeini Hospital from April and September 2020.

Materials and Methods

In this cross-sectional study, patients with thrombocytopenia, associated with COVID-19, diagnosed at the Shahid Mostafa Khomeini Hospital in Ilam City during the spring and summer of 2020 were included. A checklist was used to record the hematological indicators of the patients. Further, an analysis of data using SPSS V20 software was performed.

Results and Discussion

Overall, 66 thrombocytopenic patients were studied. Among patients who succumbed to the disease complications, 40 (67.8%) were male, and 19 (32.2%) were female. Mortality and survival rates were 90% and 10%, respectively.

Conclusion

Due to the high mortality rate of COVID-19 patients with thrombocytopenia, platelet count can be considered a major risk factor, as well as a prognostic and diagnostic indicator in these patients.

© 2026 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/covid/10.2174/0126667975319779241008050138
2024-10-16
2026-01-02

  • From This Site

    /content/journals/covid/10.2174/0126667975319779241008050138
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. WHO COVID-19 dashboard.Available from: https://data.who.int/dashboards/covid19/deaths?n=o
  2. WHO COVID-19 dashboard.Available from: https://data.who.int/dashboards/covid19/cases
  3. MattiuzziC. LippiG. Which lessons shall we learn from the 2019 novel coronavirus outbreak?Ann. Transl. Med.2020834810.21037/atm.2020.02.0632154288
     [Google Scholar]
  4. KhuranaD. DeokeS.A. Thrombocytopenia in critically ill patients: Clinical and laboratorial behavior and its correlation with short-term outcome during hospitalization.Indian J. Crit. Care Med.2017211286186410.4103/ijccm.IJCCM_279_1729307969
     [Google Scholar]
  5. VanderschuerenS. De WeerdtA. MalbrainM. Thrombocytopenia and prognosis in intensive care.Crit. Care Med.20002861871187610.1097/00003246‑200006000‑0003110890635
     [Google Scholar]
  6. HuiP. CookD.J. LimW. FraserG.A. ArnoldD.M. The frequency and clinical significance of thrombocytopenia complicating critical illness: A systematic review.Chest201113927127810.1378/chest.10‑2243
     [Google Scholar]
  7. YangM. NgM.H.L. LiC.K. Thrombocytopenia in patients with severe acute respiratory syndrome (review).Hematology200510210110510.1080/1024533040002617016019455
     [Google Scholar]
  8. HeW.Q. ChenS.B. LiuX.Q. LiY.M. XiaoZ.L. ZhongN.S. Death risk factors of severe acute respiratory syndrome with acute respiratory distress syndrome.Zhongguo Wei Zhong Bing Ji Jiu Yi Xue200315633633712837163
     [Google Scholar]
  9. ZouZ. YangY. ChenJ. Prognostic factors for severe acute respiratory syndrome: A clinical analysis of 165 cases.Clin. Infect. Dis.200438448348910.1086/38097314765339
     [Google Scholar]
  10. SongZ. XuY. BaoL. From SARS to MERS, thrusting coronaviruses into the spotlight.Viruses20191115910.3390/v1101005930646565
     [Google Scholar]
  11. ChenN. ZhouM. DongX. Pidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study.Lancet202039550751310.1016/S0140‑6736(20)30211‑732007143
     [Google Scholar]
  12. FanB.E. ChongV.C.L. ChanS.S.W. Hematologic parameters in patients with COVID‐19 infection.Am. J. Hematol.2020956E131E13410.1002/ajh.2577432129508
     [Google Scholar]
  13. LippiG. MattiuzziC. Hemoglobin value may be decreased in patients with severe coronavirus disease 2019.Hematol. Transfus. Cell Ther.202042211611710.1016/j.htct.2020.03.00132284281
     [Google Scholar]
  14. ChowdhuryS.F. Management of hemoglobin disorders during the COVID-19 pandemic.Front. Med.2020730610.3389/fmed.2020.00306
     [Google Scholar]
  15. AnaiM. Decrease in hemoglobin level predicts increased risk for severe respiratory failure in COVID-19 patients with pneumonia.Respir Investig2020S2212-5345203016010.1016/j.resinv.2020.10.009
     [Google Scholar]
/content/journals/covid/10.2174/0126667975319779241008050138
Loading
Thrombocytopenia and Other Hematological Features in COVID-19 Patients Referred to Shahid Mostafa Khomeini Hospital
Coronaviruses 7, E26667975319779 (2026); https://doi.org/10.2174/0126667975319779241008050138
/content/journals/covid/10.2174/0126667975319779241008050138
/content/journals/covid/10.2174/0126667975319779241008050138
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): COVID-19; hematological parameters; intensive care units; platelet; respiratory syndrome; Thrombocytopenia

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test